Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

Hashem B. El‐Serag(Michael E. DeBakey VA Medical Center)
Gastroenterology
April 24, 2012
Cited by 3,409Open Access
Full Text

Abstract

Most cases of hepatocellular carcinoma (HCC) are associated with cirrhosis related to chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Changes in the time trends of HCC and most variations in its age-, sex-, and race-specific rates among different regions are likely to be related to differences in hepatitis viruses that are most prevalent in a population, the timing of their spread, and the ages of the individuals the viruses infect. Environmental, host genetic, and viral factors can affect the risk of HCC in individuals with HBV or HCV infection. This review summarizes the risk factors for HCC among HBV- or HCV-infected individuals, based on findings from epidemiologic studies and meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the United States. Most cases of hepatocellular carcinoma (HCC) are associated with cirrhosis related to chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Changes in the time trends of HCC and most variations in its age-, sex-, and race-specific rates among different regions are likely to be related to differences in hepatitis viruses that are most prevalent in a population, the timing of their spread, and the ages of the individuals the viruses infect. Environmental, host genetic, and viral factors can affect the risk of HCC in individuals with HBV or HCV infection. This review summarizes the risk factors for HCC among HBV- or HCV-infected individuals, based on findings from epidemiologic studies and meta-analyses, as well as determinants of patient outcome and the HCC disease burden, globally and in the United States. According to the International Agency for Research on Cancer, liver cancer is the fifth most common cancer in men worldwide (523,000 cases/y, 7.9% of all cancers) and the seventh most common cancer in women (226,000 cases/y, 6.5% of all cancers). Liver cancer has a high mortality rate; the geographic distribution of mortality is similar to that of incidence. Most of the burden of liver cancer is in developing countries, where almost 85% of the cases occur. Hepatocellular carcinoma (HCC) is the most common form of liver cancer; most cases of HCC (approximately 80%) are associated with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infections. Variations in the age-, sex-, and race-specific rates of HCC in different geographic regions are likely to be related to differences in the prevalence of hepatitis viruses in the populations, as well as the timing of the spread of the viral infection and the age of individuals at the time of the infection. Most cases of HCC (>80%) occur in sub-Saharan Africa and in Eastern Asia, with typical incidence rates of more than 20 per 100,000 individuals. Southern European countries (such as Spain, Italy, and Greece) tend to have mid-incidence levels (10.0–20.0 per 100,000 individuals), whereas North America, South America, Northern Europe, and Oceania have a low incidence of HCC (<5.0 per 100,000 individuals) (Figure 1). Recent decreases in the incidence of HCC were reported among Chinese populations in Hong Kong, Shanghai, and Singapore; the incidence in Japan also is decreasing. However, cases of HCC are increasing in low-incidence areas such as the United States and Canada. HCC rarely is seen during the first 4 decades of life, except in populations in which HBV infection is hyperendemic. The mean ages of diagnosis with HCC were 55–59 years in China and 63–65 years in Europe and North America. In low-risk populations, the highest incidence of HCC is among individuals aged 75 or older. However, in Qidong, China, where HCC burden is among the world's highest, the age-specific incidence rates among men increases until age 45 years and then plateaus; among women, the incidence rate increases until age 60 years and then plateaus. HCC is predominant among men, with the highest male:female ratios in areas of high incidence (Figure 1). HBV and HCV promote cirrhosis, which is found in 80%–90% of patients with HCC. The 5-year cumulative risk of developing HCC for patients with cirrhosis ranges between 5% and 30%, depending on etiology (it is highest in individuals with HCV infection), region or ethnicity (it is highest in Asians), and stage of cirrhosis (it is highest in individuals with decompensated disease).1Fattovich G. Stroffolini T. Zagni I. et al.Hepatocellular carcinoma in cirrhosis: incidence and risk factors.Gastroenterology. 2004; 127: S35-S50Abstract Full Text Full Text PDF PubMed Scopus (2061) Google Scholar Approximately 5% of the world population (350–400 million people) is chronically infected with HBV; 75% of infected people are Asian,2McMahon B.J. Alberts S.R. Wainwright R.B. et al.Hepatitis B-related sequelae Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.Arch Intern Med. 1990; 150: 1051-1054Crossref PubMed Google Scholar with a lower prevalence (0.3%–1.5%) in Western countries. There is high ecologic correlation between areas of HBV prevalence and HCC incidence and mortality worldwide (Figure 2). Chronic HBV infection accounts for approximately 50% of the total cases and virtually all childhood HCC; it is the dominant risk factor in most areas of Asia and sub-Saharan Africa that have a high incidence of HCC, with the exception of Japan, where the major risk factor for HCC is chronic HCV infection. HB surface antigen (HBsAg) seroprevalence among persons with HCC varies widely: it is 3% in Sweden, 10% in the United States, 10%–15% in Japan, 19% in Italy, 55% in Greece, and 70% in South Korea. The global prevalence of HCV is estimated to be 2% (approximately 180 million people worldwide) and varies considerably among different regions (Figure 2). Phylogenetic studies of HCV diversity described the chronology of the spread of HCV epidemics in Japan, Europe, and the United States; these findings account for the geographic differences in the timing of the burden of HCV-related HCC.3Mizokami M. Orito E. Molecular evolution of hepatitis PubMed Scopus Google Scholar on these HCV to of in Japan in the in Europe in the and in North in the and et of the global hepatitis C virus of hepatocellular carcinoma Full Text Full Text PDF PubMed Scopus Google Scholar The HCV in the United States from The virus spread and until the the rate of the seroprevalence of HCV is similar among the populations of Japan, Europe, and North America, of HCV infection are highest among individuals with HCC in Japan and then the United States Hepatocellular and Full Text Full Text PDF PubMed Scopus Google Scholar The incidence of HCC is almost in Japan than and almost than in the United States. The burden of HCC in the United States that of The age distribution of HCC in different regions is of virus and timing of infection. In areas that have a high incidence of HCC in Asia, HBV infection is whereas among of ages is more common in individuals in these regions HCC at ages than in low-incidence where the risk factors for HCV infection are in in prevalence of HCC affect and of such as liver The high male:female of HCC in from the prevalence of HBV and HCV infection among men than is estimated that more than of countries and approximately 70% are In the first to and HB to of and HB antigen the of HBV in the population has and the incidence of HCC among aged years B virus and cancer PubMed Scopus Google Scholar However, the incidence of HCC is to for decades of the high prevalence of chronic HBV infection and to HCC Prospective studies a to in the risk of developing HCC among persons chronically infected with of and studies that the risk for HCC among individuals, with individuals. review of studies et G. of chronic hepatitis on disease and Full Text Full Text PDF PubMed Scopus Google Scholar estimated the incidence rates of HCC in with chronic HBV infection in countries to be per in with levels of for with chronic HBV infection cirrhosis, and for with There have studies in Europe or North to the incidence of HCC in studies of the HCC incidence rate per in in with chronic HBV cirrhosis, and in with Most individuals HCC have cirrhosis to chronic HBV can HCC in the of cirrhosis, most cases of HCC occur in patients with et is in most patients with hepatitis B and hepatocellular Full Text Full Text PDF PubMed Scopus Google Scholar that have reported to HCC risk among HBV are or of viral levels of HBV HBV of with virus or hepatitis and to of or In in Asia, HBV is from to as as of infected chronic infections. This is different in areas that have a low incidence of HCC; HBV infection is in and than of these cases of HBV infection The and of chronic HBV to a risk for HCC in areas where HBV infection is The risk of HCC is in patients with levels of HBV for and levels of HBV study the of HBV on the risk of HCC among men were for a mean of The incidence rate of HCC per 100,000 among men were and per 100,000 for were and per 100,000 for were the of HCC among men were and were and among were et al.Hepatitis B antigen and the risk of hepatocellular Med. PubMed Scopus Google Scholar the of and Liver B reported that in a of the incidence of cirrhosis and HCC in to the of HBV from than to or more (Figure for and B virus levels and in chronic hepatitis PubMed Scopus Google Scholar The incidence in HCC in to also in a study that that of HBV for levels of HBV and liver almost risk for HCC than et of hepatitis B virus are at risk for hepatocellular carcinoma and Full Text Full Text PDF PubMed Scopus Google Scholar is the findings from to Western populations, HBV as and have different risk factors for disease and of viral also are There is that which HBV infection in risk for HCC. In a patients with chronic HBV and cirrhosis or were of or for to of patients HCC with which a of HBV et for patients with chronic hepatitis B and liver Med. 2004; PubMed Scopus Google Scholar from and studies has that with or the risk for et of hepatitis B infection risk of hepatocellular PubMed Scopus Google Scholar HBV have based on differences of or more in their HBV have geographic and and in Europe, and B and C in in and in and South America. In the United States, HBV and are more common in and whereas HBV B and C are more common among persons of HBV to affect In studies in Asia, a between C infection and liver cirrhosis, and HCC than in Western Europe and North America, individuals with a incidence of liver disease or HCC than with However, B HBV with the of HCC in study from that B more common in patients with HCC than age than in with et of hepatitis B virus the risk of hepatocellular carcinoma in hepatitis B Full Text PDF PubMed Scopus Google Scholar Most of these have study of of HBV reported that B the most among with HCC in et of hepatitis B virus in with chronic infection and hepatocellular 2004; 127: Full Text Full Text PDF PubMed Scopus Google Scholar in the region of the HBV that the such as and et of hepatitis B viral and in hepatocellular carcinoma in hepatitis B PubMed Scopus Google Scholar have associated with incidence of HCC, whereas in the region have associated with incidence of et between hepatitis B virus and and the risk of hepatocellular PubMed Scopus Google Scholar is a of the and that on such as and in In is a the International Agency for Research on to it as a is to which can to and a at in the Liver of B to a to Google Scholar that in of HCC from individuals in most of HBV M. et to of in hepatocellular carcinoma from PubMed Scopus Google et of and hepatitis viruses in the of hepatocellular a for in PubMed Scopus Google Scholar have to in and in and to in in which is also have a high prevalence of chronic HBV infection. to its in the of HCC is its on chronic HBV infection. studies in Shanghai, China, that of the risk of HCC to and HBV infection the risk However, individuals and were of HBV as as a in risk of et study of of and liver cancer risk in Shanghai, of Google Scholar of HCC the of on HCC with have that HBV in or as HBV among persons have from HBV infection are In hepatitis B is associated with to hepatitis B antigen review studies of the between HBV and HCC of these studies found of the studies in review a of cases or were from Asia in the United and and for be for 4 studies from that a between HBV infection and HCC et between hepatitis B infection and the risk of hepatocellular a PubMed Scopus Google Scholar study from Hong a high prevalence of HBV in patients with et hepatitis B infection and HBV in patients with of hepatocellular PubMed Scopus Google Scholar However, is that HBV is risk factor for HCC or a with HCV infection in most regions of the There is that HCV infection can HCC. Prospective studies have a in the incidence of HCC among HCV-infected with et risk of stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C PubMed Scopus Google Scholar The rate of HCC among HCV-infected persons ranges from to 3% HCV infection is associated with a to in risk for HCC with in and HCV increases the risk for HCC HCC has reported among individuals or with low levels of et liver cancer Full Text PDF PubMed Scopus Google et between chronic hepatitis C infection and hepatocellular PubMed Google of hepatocellular carcinoma of hepatitis C virus with Med. Google Scholar the risk of HCC increases with most cases of HCV-related HCC occur among patients with or cirrhosis, it a for HCC in HCV-related cirrhosis is HCC at rate of rates to have reported in The incidence of cirrhosis years HCV infection ranges from to et to cirrhosis in chronic hepatitis C virus PubMed Scopus Google Scholar and is highest among of and and among women a of HCC risk also based on the of virus in the or risk factors for HCC the of the HCV-infected with HBV or viral of and patients with HCV-related cirrhosis, low of or levels of are risk factors for HCC. HCV of is a risk factor for HCC; that the virus decreases risk for HCC. from studies and studies of HCV-infected patients with and cirrhosis a to 75% in risk of HCC in patients and a viral There are at HCV which in of in the There are also HCV and are the most common in the United States and Europe, whereas in Japan, of HCV-infected individuals of the between HCV and HCC risk are However, a of studies that risk reported that patients infected with HCV almost risk of developing HCC than patients with HCV The risk lower in to studies in patients with cirrhosis et al.Hepatitis C virus as a risk factor for hepatocellular carcinoma a Full Text Full Text PDF PubMed Scopus Google Scholar There is that viral such as HCV or affect the risk of to cirrhosis or HCC. study in reported a correlation between of HCV and the risk of et al.Hepatitis C virus and risk of hepatocellular from a PubMed Scopus Google Scholar studies from the United States and Europe have studies the of infection on the of HCV-related liver cirrhosis, HCC, decompensated liver and studies the or study the of these studies and it that persons with have to cirrhosis and decompensated liver during However, the of on liver disease in patients with HCV and is 4 studies in a review with risk for HCC, it is to of the of cases of HCC in these the risk for HCC, the between and liver of virus and on of hepatitis a review from epidemiologic Full Text Full Text PDF PubMed Scopus Google Scholar HBV infection in of with than 5% of infection. individuals with and HBV have risk for However, are on the of with HBV and on risk for HCC. studies have associated high levels of with levels of and and incidence of chronic liver of high levels of associated with in patients with chronic HCV et is associated with PubMed Scopus Google Scholar also associated with of liver disease among in the C hepatitis or cirrhosis and have a to and et is associated with lower rates of liver disease in chronic hepatitis PubMed Scopus Google Scholar In the C of from than or of associated with levels of liver or studies have between and risk of HCC. of studies studies cases of HCC; studies from Europe and Japan and 4 studies from the geographic of these most patients with HCC were infected with or the studies between and risk of HCC, and in studies the The risk for from studies and from estimated that for of of per the risk from studies and from et and hepatocellular carcinoma a PubMed Scopus Google and risk of liver a Full Text Full Text PDF PubMed Scopus Google Scholar The which the risk of liver HCC, are a risk for In to such as and are similar to in also HCC levels of and the risk for et and in to a review with Intern Med. PubMed Scopus Google Scholar a risk factor for liver cirrhosis, and HCC. are at risk for HCC have a incidence of viral hepatitis and However, their risk is for these have risk of cirrhosis and HCC from different such as HBV and HCV infection. levels of have associated with HCC risk in studies of HBV in and et study of and hepatocellular carcinoma in Shanghai, PubMed Scopus Google Scholar of HBV have viral of HBV infection in that the can the of HBV to in the viral the HBV can the of et al.Hepatitis B virus depending on PubMed Scopus Google of hepatocellular the of PubMed Scopus Google Scholar studies have reported that of HBV infection. There have studies of the of in HCV-related liver There have from studies of HCV-infected patients total levels of and of HCV-related study associated total levels of with risk of and in with chronic HCV in the United States. However, the with HCC et is associated with risk of hepatitis liver disease in PubMed Scopus Google Scholar There has study to the risk of HCC among patients with HBV and HCV of studies from countries M. of studies on the of hepatitis B and C virus in hepatocellular PubMed Scopus Google Scholar and China et of studies on the of hepatitis B and C virus in hepatocellular carcinoma in PubMed Scopus Google Scholar reported the of HBV and HCV on risk for HCC. of studies et M. of studies on the of hepatitis B and C virus in hepatocellular PubMed Scopus Google Scholar found that infection with HBV and HCV of for HCC, with of for HCV infection and of for HBV infection In a of Chinese studies that cases and the for for HCV and HCV the and for and and HCV the et of studies on the of hepatitis B and C virus in hepatocellular carcinoma in PubMed Scopus Google Scholar However, that studies that HBV and HCV reported a on HCC based on more studies and studies in areas in which HBV and HCV infection were it reported in and studies in areas where HCV infection et of hepatitis B and C viruses and risk of hepatocellular review and PubMed Scopus Google Scholar of HBV and HCV is infection with virus can infection with the There is of a between of and HCV infection to a HBV these factors to promote of 20 studies between and that more than persons with chronic HCV infection reported that the risk of cirrhosis associated with with or of on the of hepatitis C virus a Full Text Full Text PDF PubMed Scopus Google Scholar This also has in the of HCC. et et and hepatocellular the of and hepatitis virus in men and PubMed Scopus Google Scholar reported among HCC risk in a with than 60 of of or of However, HCV infection risk for HCC (Figure studies have the between HBV infection and or of different of study of patients with cirrhosis that the risk for HCC et and hepatocellular in patients with chronic viral a of Full Text PDF PubMed Scopus Google Scholar study in found that among individuals with chronic HBV the risk for HCC among with of or with a risk of for and of for than et hepatitis and risk for hepatocellular carcinoma in 2004; PubMed Scopus Google Scholar The between and HCC has in more than 60 in areas of high and low incidence of HCC; and have reported in different studies found that were to HBV or HCV In a of that the epidemiologic between HBV and HCV and risk of HCC, a more than between HBV infection and and a more than between HCV infection and M. et between and hepatitis B and C virus infection on the risk of liver a PubMed Scopus Google Scholar is associated with and HCC among patients with HCV infection. of studies reported of associated with HCC in studies and that of associated with HCC in studies risk The between HCC and of viral hepatitis or in the studies that these The between and hepatocellular a review of epidemiologic Full Text Full Text PDF PubMed Scopus Google Scholar review of studies reported on a total of studies and The risk of studies than that from studies et and risk of hepatocellular a review and PubMed Scopus Google Scholar and and also to HCC, it to the between HCC and This is likely to be in studies that patients with liver disease at The between and HCC on the of viral infection. There is a in among HCV-infected individuals, with individuals, based on and with HCV infection also have a risk of than C infection and risk of a review and Full Text Full Text PDF PubMed Scopus Google Scholar However, studies found that HCV and to the risk of et factors for hepatocellular of with viral hepatitis and PubMed Scopus Google The of in hepatocellular a study among United States PubMed Google Scholar The between and HCC is in areas with a high incidence of HBV infection than in a study reported a between and risk for et and cancer risk in men and PubMed Scopus Google Scholar studies et and hepatocellular a study in high prevalence of hepatitis virus PubMed Scopus Google Scholar with HCV are on or and risk of liver HCC, among individuals with HBV infection. study from HCC cases and and levels of reported that the risk of HCC among men with chronic HBV with a of for in the highest of levels and a of for with the levels of for et and hepatocellular carcinoma risk in hepatitis B from of a PubMed Scopus Google Scholar Most individuals with HCV or HBV cirrhosis or HCC. of liver cancer has associated with risk for HCC among HBV and and among HCV-infected persons of viral et of of liver cancer with hepatocellular a study in the United Full Text Full Text PDF PubMed Scopus Google et risk of hepatocellular carcinoma among chronic hepatitis B and their PubMed Scopus Google Scholar factors account for of the in the risk of developing cirrhosis or HCC. studies are and or has as to the of on risk of the of common in with risk for HCC. studies that cancer cases and and associated the and with a risk of HCC in different a dominant that of factor and hepatocellular carcinoma a Google Scholar The studies HCC cases and reported that patients with HCC a lower of the than more than T. et and hepatocellular a PubMed Scopus Google Scholar the between in and and the risk for HCC in studies studies were patients with HCC and This the between a at and HCC in The and and were associated with the risk for et and and risk for hepatocellular a PubMed Scopus Google Scholar of are among the most risk factors for HCC. are a of that that the of that in and et of as risk factors for hepatocellular a review and PubMed Scopus Google Scholar in studies cases and that of or that a the risk for HCC, findings for of studies that studies HCC cases and also a in risk for HCC among individuals with the of and that the in risk for HCC in areas where HBV infection G. et of and to hepatocellular carcinoma from Full Text Full Text PDF PubMed Scopus Google Scholar of cases of HCC and found between the that and the risk of et and hepatocellular carcinoma a PubMed Scopus Google Scholar from the of and which have in epidemiologic studies to be associated with HCC to to HCC risk in patients with chronic HBV M. et for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus PubMed Scopus Google Scholar of risk of HCC, levels of levels of HBV and HBV were to based on from in the these were in of The have to and However, it is these can be to the and to There is such for HCC among HCV-infected In the United States, the incidence rates for HCC have the rates are to lower among than and to lower among than or men and have the highest incidence rates high as per However, the increases have among and whereas the increases have among In the age distribution of HCC patients has to with the increases among individuals years patients with HCC in the United States, are infected with 10%–15% are infected with than 5% are infected with and are infected with HCV infection is the most reported factors in and with HCC, whereas HBV infection is the most reported factor in with HCC. studies have variations in risk factors among patients with HCC in the United States; in studies from where viral risk factors were based on and in the studies were from in which risk factors were International of in or In all these HCV-related HCC the whereas the of HCC associated with HBV infection in studies and in among persons aged years and older. The rate of HCC related to liver disease in all 4 trends have HCV-related mortality and or based on from liver In the United States, the incidence of HCC is likely to HBV HCC, it cancer in persons with chronic infections. The most and estimated that of the population, years or chronic HBV et of hepatitis B virus infection in the United States, from the and PubMed Scopus Google Scholar However, studies of and of and persons from the and Africa a prevalence of chronic HBV infection The incidence of HCV-related cirrhosis and HCC in the United States has increasing (Figure and to for a more The and also estimated that of the population chronic HCV approximately of infected were between and and have with the infection for This also risk factors for such as and estimated that approximately 50% of individuals with chronic HCV in the United States are the of patients with cirrhosis or HCC et of hepatitis C virus persons in the United a of HCV prevalence and disease Full Text Full Text PDF PubMed Scopus Google Scholar a in the total of people with liver HCC, from cases in to in et al.Hepatocellular risk factors and PubMed Scopus Google Scholar In HCC incidence and mortality be from of have in areas of high and China and Japan, and increasing in low-incidence the United States and Canada. The of HCC cases associated with HBV has whereas the associated with HCV has However, region or can be its mortality from European countries that between and the mortality from HCC among men in and it in and et in mortality from hepatocellular carcinoma in Europe, PubMed Scopus Google Scholar HBV and HCV the risk factors for HCC. has estimated that be a in HCV-related mortality worldwide between and which can be as high as a in the with the highest prevalence of HCV et in hepatitis mortality in to Full Text Full Text PDF PubMed Scopus Google Scholar The of on and Liver the of HBV and HCV and the and of their HBV- and HCV-related HCC be increasing and of infected to viral global of and patients with chronic HBV and HCV for and and for and of viral hepatitis and hepatocellular PDF


Related Papers